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Abstract 
Background: Mastectomy is the most common procedure for treatment of mammary tumours. Dogs undergoing 
mastectomy have a risk of developing surgical site infections (SSI) and other postoperative complications. However, 
potential risk factors associated with such complications have been sparsely investigated. Thus, the objective of this 
retrospective study was to determine the incidence of, and identify risk factors for, SSI and non-SSI postoperative com-
plications after mastectomy performed without perioperative antimicrobial prophylaxis in privately owned otherwise 
clinically healthy dogs.
Results: Medical records were reviewed retrospectively for 135 client-owned female dogs, 10–35 kg in weight and 
three to 10 years of age, which had undergone mastectomy due to mammary tumours at three referral animal hospi-
tals in Sweden over a 3-year period. Twelve (8.9%) dogs developed SSI, and 21 dogs (17.1%) dogs suffered a non-SSI 
postoperative complication. The incidence of SSI and all complications (SSI and non-SSI) were higher in dogs that had 
two to three (SSI: P = 0.036 and all complications: P = 0.0039) and four to five (SSI and all complications: P = 0.038) 
mammary glands excised, compared to dogs that had one mammary gland excised. The incidence of SSI was 1.7% 
(n = 1/60) in dogs that had one gland removed. The incidence of non-SSI postoperative complications was higher in 
dogs with a higher body weight (P = 0.02).
Conclusions: The incidence of SSI was lower than or similar to previously reported incidences of SSI in dog popula-
tions that have undergone tumour excisional surgery, despite the fact that dogs in the present study had not received 
perioperative antibiotics. Dogs that had two or more glands excised had an increased risk of developing SSI and 
non-SSI complications compared to dogs that had one gland excised. Furthermore, higher BW was associated with an 
increased risk of non-SSI complications. Results from the study indicate that routine use of perioperative antibiotics in 
tumour excisional surgery can be questioned, at least in single gland mastectomy in otherwise clinically healthy dogs.
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Background
Mammary tumours are one of the most common types 
of neoplasia in female dogs and account for about half of 
all tumours in intact female dogs [1–4]. Mastectomy is 
the most common procedure for treatment of mammary 
tumours [5]. Dogs undergoing mastectomy, as well as 
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surgery, have a risk of developing surgical site infection 
(SSI) and other postoperative complications [6–8]. To 
minimise the risk of SSI, the surgeon should take sev-
eral pre-, intra- and postoperative precautions. Pre- and 
intraoperative precautions include stringent cleaning of 
the surgical area and aseptic surgical techniques, mini-
misation of dead space, efficient haemostasis and atrau-
matic tissue handling, including avoidance of excessive 
stretching of the skin when closing the wound [9–12].
Despite meticulous technique and careful precautions, 
SSI can occur and remains an important cause of postop-
erative morbidity [13]. Perioperative antimicrobial ther-
apy has been suggested to prevent SSI in dogs undergoing 
reconstructive surgery [6, 8], and perioperative antimi-
crobial therapy has been recommended by some authors 
for procedures where surgical time exceeds 90 min [13]. 
However, because multi-resistant bacteria have emerged 
as a world-wide health problem, various factors associ-
ated with the development of SSI and other postoperative 
complications need to be further elucidated in patients 
undergoing surgery in order to potentially reduce routine 
use of antimicrobial perioperative prophylaxis.
Thus, the objective of this retrospective study was to 
determine the incidence of, and identify risk factors for, 
SSI and non-SSI postoperative complications after mas-
tectomy performed without perioperative antimicro-




Medical records were reviewed retrospectively from 
three referral animal hospitals in Sweden: the University 
Animal Hospital at the Swedish University of Agricul-
tural Sciences in Uppsala, Evidensia South Animal Hos-
pital in Stockholm, and AniCura Albano Animal Hospital 
in Stockholm. Records from female dogs that had under-
gone standardised surgical procedures to remove mam-
mary tumours, ranging from single gland mastectomies 
to unilateral total mastectomies, between 1 July 2013 and 
30 September 2016 were evaluated. Dogs that had under-
gone previous mastectomy within a 2-month period 
prior to the surgery were excluded. To avoid certain 
individuals being given too much weight in the analysis, 
only the first surgery for each dog during the time period 
was included. Dogs of any breed were eligible for inclu-
sion in the study if they were between the ages of three 
to 10 years at the time of surgery and had a body weight 
(BW) between 10 and 35  kg. Only dogs with informa-
tion available in the medical records regarding the wound 
healing process during the first month postoperatively 
were included.
Dogs suffering significant concurrent systemic or organ 
related diseases or disorders that could affect wound 
healing (e.g. endocrine and skin disease processes) were 
excluded. Dogs were also excluded if they had been 
treated with perioperative antibiotics during the mastec-
tomy or if they had been treated with substances at the 
time of surgery that potentially could affect wound heal-
ing, such as corticosteroids. Furthermore, dogs that had 
undergone surgery where several non-coherent glands 
had been excised, where solely lumpectomies had been 
performed, or concurrent surgery not concerning exci-
sion of mammary gland tumours (e.g. celiotomies or 
excision of non-mammary gland tumours) were excluded 
from the study.
Medical record information
All medical records from dogs included in the study were 
studied at a minimum of 1 month postoperatively. Patient 
records and bacteriological culture results were compiled 
with owner permission.
All records were compiled by the same veterinar-
ian (PS). The following variables were registered in the 
dataset: dog breed; age; BW; neutering status; season 
(defined as winter: December until the end of February; 
spring: March until the end of May; summer: June until 
the end of August; and fall: September until the end of 
November) when surgery was performed, hospital (1–3); 
number of mammary glands excised (group 1—one 
gland excised; group 2—two or three glands excised; or 
group 3—four or five glands excised); anatomical locali-
sation of glands excised (cranial glands, defined as num-
ber one to three; caudal glands, defined as number four 
to five; or a combination of both); length of anaesthesia 
(defined from the time of induction to the time of extu-
bation); type of tumour/s excised; SSI or non-SSI post-
operative complication, of which the latter included, but 
was not limited to, seroma, dehiscence and suture reac-
tion; number of days postoperatively when complications 
occurred; and results from potential bacterial culture. 
Dogs that developed an SSI could not also be registered 
as having a non-SSI postoperative complication, because 
such complications could be associated with the devel-
opment of SSI, and the cause-effect relationship might 
therefore be unclear. Verification of a diagnosis of SSI 
in a dog required that signs described in the medical 
records fulfilled the necessary criteria (Table  1), which 
were adapted and modified from the Centers for Disease 
Control and Prevention (CDC) guidelines [14]. A dog 
that did not fulfil the necessary criteria for SSI accord-
ing to CDC-guidelines, and that had a positive bacterial 
growth cultured from the incision considered as normal 
skin microbiota, was not considered to suffer from SSI. 
All suspected SSI cases were evaluated and verified based 
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on the information gained from the journals by two of 
the authors (PS and AB).
Tumours were classified as malignant or benign based 
on the pathology report.
Statistical analyses
Statistical analysis was performed using commercially 
available software.1 Data are presented as medians and 
interquartile range (IQR). A value of P < 0.05 was con-
sidered significant for all analyses. Univariable logistic 
regression analysis was used to analyse potential asso-
ciations between SSI and non-SSI postoperative com-
plications, individually and in combination, and season, 
hospital, age, BW, neuter status, number and anatomical 
localisation of glands excised, length of anaesthesia, and 
type of tumour/s excised. Odds ratio and 95% confidence 
intervals were calculated.
Results
Data from a total of 135 female dogs were included in the 
study (Table 2). These consisted of 23 mixed breed dogs, 
nine English Springer Spaniels, nine Labrador Retriev-
ers, seven Cocker Spaniels and 51 different other breeds 
with one to five dogs represented from each breed. Fifty-
five, 43 and 37 dogs, respectively, were recruited from the 
three hospitals. Forty-two surgeries were performed in 
the summer, 37 in the autumn, 31 in the winter and 25 in 
the spring.
In all of the surgeries, anaesthesia was induced with 
propofol and maintained with inhalation anaesthe-
sia, using isoflurane or sevoflurane in oxygen. Infor-
mation about the length of anaesthesia was available 
for 124/135 (91.9%) of the dogs. The median length of 
anaesthesia was reported to be 90  min (IQR 65–120) 
in these 124 dogs, and 63 of the dogs were anesthe-
tized ≤ 90  min and 61 of the dogs were anesthetized 
> 90  min. The training level of the surgeons ranged 
from non-specialists to board certified specialists in 
surgery. Surgeries in all the included dogs was per-
formed according to a standardised procedure: an ellip-
tical incision was made around the mammary gland(s) 
to be excised. The tissue was subcutaneously dissected 
with sharp and blunt dissection. If necessary, the fas-
cia was partially removed in case of minimal margins or 
adherence to the tumour/tumours. Suturing was per-
formed with monofilament sutures in all layers, absorb-
able in fascia and subcutaneously and non-absorbable 
in the skin.
The number of dogs developing surgical site infection 
(SSI) and various other postoperative complications 
is presented in Table  2. The SSIs were detected at a 
median of 8 days postoperatively (IQR 5–10). The inci-
dence of SSI was 1.7% (n = 1/60) in the dogs that had 
one gland excised, 14% (n = 8/57) in the dogs that had 
two to three glands excised, and 16.7% (n = 3/18) in the 
dogs that had four to five glands excised (Fig. 1).
Bacteriological culture had been obtained in 11 of the 
12 dogs deemed affected by SSI, and 10 of these cultures 
(91%) had positive growth. All cultured bacteria were 
sensitive to amoxicillin. Staphylococcus pseudintermedius 
was the most common organism cultured (eight cases).
Non-SSI complications were detected at a median 
of 9  days postoperatively (IQR 6–13). The incidence 
of non-SSI postoperative complication was 10.2% 
(n = 6/59) in the dogs that had one gland excised, 24.5% 
(n = 12/49) in the dogs that had two to three glands 
excised, and 20% (n = 3/15) in the dogs that had four to 
five glands excised (Fig. 2).
A benign tumour was diagnosed by histopathology 
in 88 dogs (65%) and a malignant tumour in 35 (26%) 
dogs. The tumour type was determined in 12 (9%) dogs.
Table. 1 Criteria for diagnosis of superficial incisional surgical site infection
The criteria used were adapted and modified after Centers for Disease Control and Prevention (CDC) guidelines [14]. The criteria described had to be met for a dog to 
be given a diagnosis of superficial incisional surgical site infection (SSI) in the study
Criteria for diagnosis of superficial incisional SSI:
Date of event occurred within 30 days after surgical procedure, where day 1 was the procedure date
AND Only the skin and the subcutaneous tissue of the incision were involved
AND The patient had at least one of the following signs of infection:
• Purulent drainage from the superficial incision
• Organism(s) was (were) identified from an aseptically-obtained specimen from the superficial incision or subcutaneous tissue by a culture or non-
culture based microbiologic testing method, which was performed for purposes of clinical diagnosis or treatment
• Superficial incision had been deliberately opened by a surgeon but culture or non-culture based testing of the superficial incision or subcutaneous 
tissue had not been performed
AND Patient had at least one of the following clinical signs:
Localized pain or tenderness; localized swelling; erythema; and/or heat
1 JMP® Pro version 14.0.0, SAS Institute Inc. Cary, NC.
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Univariable logistic regression analysis
A positive association was found between diagnosis of 
SSI and number of mammary glands excised (P = 0.015): 
the incidence of SSI was higher in dogs that had two to 
three (OR 9.6, 95% CI 1.2–79.7, P = 0.036) and four to 
five (OR 11.8, 95% CI 1.1–121.7, P = 0.038) mammary 
glands excised, compared to dogs that had one mam-
mary gland excised. A positive association was also found 
between all complications (SSI and non-SSI postop-
erative complications) and number of mammary glands 
excised (P = 0.0063): the incidence of all complications 
was higher in dogs that had two to three (OR 4.1, 95% 
CI 1.6–10.7, P = 0.0039) and four to five (OR 3.8, 95% CI 
1.1–13.3, P = 0.038) mammary glands excised, compared 
to dogs that had one mammary gland excised. The inci-
dence of non-SSI postoperative complication was higher 
in dogs with a higher BW (OR 1.1, 95% CI 1.0–1.18, 
P = 0.020).
Discussion
In the present study, the incidence of SSI was lower 
than, or similar to, previously reported incidences in dog 
populations that have undergone tumour excisional sur-
gery, despite the fact that all mastectomies had been per-
formed without perioperative antimicrobial prophylaxis. 
Dogs that had undergone more extensive mastectomy 
were found to have an increased risk of developing post-
operative complications compared to dogs that had one 
gland excised.
The overall incidence of SSI was 8.9% in the present 
study, which included dogs that had undergone mastec-
tomies ranging from single gland mastectomies to radi-
cal mastectomies. The incidence of SSI has previously 
been reported to be 17% in dogs that have undergone 
regional mastectomy, 23% in dogs that have under-
gone radical mastectomy [7], and 9% in dogs that have 
Table. 2 Age, bodyweight, neutering status, number of mammary glands removed and incidence of postoperative complications; 
including surgical site infection (SSI), in 135 female dogs with mammary tumours
a Other complications include signs of mild redness or swelling without exudation or pain
Dog characteristics (n = 135) Mammary glands removed
1/2–3/4–5
Postoperative complications
Age (years) BW (kg) Intact/neutered











Fig. 1 Incidence of dogs that developed surgical site infection 
postoperatively grouped according to number of glands surgically 
removed
Fig. 2 Incidence of dogs that developed any kind of complication 
postoperatively grouped according to number of glands surgically 
removed
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undergone mastectomies ranging from small lumpecom-
ties to radical mastectomies [15]. All dogs included in 
these previous published studies had been administered 
perioperative antibiotics. In contrast, dogs included in 
the present study had not been treated with periopera-
tive antibiotics. The incidence of SSI of 1.7% in dogs that 
had one gland excised in the present study population 
clearly indicates that perioperative antibiotics are super-
fluous for single gland mastectomy in an otherwise clini-
cally healthy dog. This is in agreement with previously 
published recommendations [13] and reinforces the 
indication that the prophylactic use of antibiotics should 
be based on individual risk assessments. Also, for more 
extensive mastectomies, the incidence of SSI in our study 
population was lower than previously reported by Horta 
et  al. [7]. Based on the results from the present study, 
which are in line with previously published studies [16, 
17], the efficacy of the routine prophylactic use of perio-
perative antibiotics in dogs undergoing mastectomies can 
be called into question.
Dogs that had two or more glands excised had a higher 
risk of developing SSI and non-SSI complications com-
pared to dogs that had one gland excised. Dogs that have 
several glands excised may have had longer anaesthesia 
and surgery periods, and the length of anaesthesia and 
surgery has previously been reported to be a risk factor 
for the development of SSIs [18]. However, the higher 
incidence of SSI could not be explained by the length of 
anaesthesia in the present study, which is in agreement 
with findings from a recently published canine mas-
tectomy study [15]. Dead space has been suggested to 
be a risk factor for the development of seromas, which, 
according to human mastectomy studies, may increase 
the risk of SSI and other morbidities [19–22]. With an 
increasing number of glands excised, the wound becomes 
increasingly larger, and as more tissue is removed, the 
potential dead space increases despite attempts to close 
dead space by suturing. The tension in the suture line 
may, furthermore, be higher in larger wounds, leading to 
disrupted micro circulation and impaired healing, and 
thereby prolonged damage to the skin barrier and devel-
opment of SSI [12].
High BW was associated with a higher risk of compli-
cations other than SSI. The influence of incisional size, 
which commonly increases with an increasing dog size, 
on the development of post-operative complications 
could potentially describe the association demonstrated. 
Incisional length has previously been reported to be a 
risk factor for SSI in horses [23]. Post-operative compli-
cations have also previously been shown to be associated 
with higher BW in dogs [15, 24]. A potential influence of 
body fat reserves could not be investigated in the current 
study as information about body condition score was 
missing in many of the medical records.
Previous studies in humans have indicated positive 
associations between SSI and warmer periods of the year 
[25, 26]. Interestingly, we did not see any effect of season 
on the incidence of SSI.
Study limitations for present study include the ret-
rospective design. The direct consequences of the ret-
rospective study design are that the authors have not 
examined all the dogs themselves. Additionally, as dogs 
were excluded if the medical records were not complete 
with regard to data pertaining to wound healing, a num-
ber of dogs without complications may not have been 
included, as owners or referring clinicians may have 
removed sutures and provided post-operative care. This 
may result in an overestimation of the true incidence of 
post-operative complications based on the current mate-
rial. Furthermore, conclusions drawn from the present 
study may not be valid for dogs with concurrent sys-
temic disease processes and dogs older than 10  years, 
as such dogs were not included in the dog population 
investigated.
Conclusions
The incidence of SSI was lower than or similar to previ-
ously reported incidences of SSI in dog populations that 
have undergone tumour excisional surgery, even though 
dogs in the present study had not received perioperative 
antibiotics. Dogs that had two or more glands excised 
had an increased risk of developing SSI and non-SSI 
complications, compared to dogs that had one gland 
excised; however, the finding could not be explained by 
the length of anaesthesia in this retrospective study. Fur-
thermore, higher BW was associated with an increased 
risk of developing non-SSI complications. Results from 
the study indicate that the efficacy of the routine use of 
perioperative antibiotics in tumour excisional surgery, 
such as mastectomies, can be called into question and 
may be considered unnecessary, at least in cases where 
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